ACTU vs BILL · $49.0M cap vs rev $1.46B
Actuate Therapeutics, Inc. Common stock (ACTU) versus Bill Com Holdings Inc (BILL) — a side-by-side from cached financials, not a winner call.
Actuate Therapeutics, Inc. Common stock (ACTU) is a biotechnology company listed on NASDAQ.
Bill Com Holdings Inc (BILL) is a software - application company listed on US.
ACTU does not have a complete income-statement cache yet.
Latest reported BILL revenue for 2025-06-30 was $1.46B. Net income was $23.8M. Revenue was up 13.4% from 2024-06-30 to 2025-06-30. BILL currently screens at market cap $4.78B.
ACTU currently screens at market cap $49.0M. BILL currently screens at market cap $4.78B.
Not investment advice. Open the ACTU and BILL stock pages for the full models.
Not investment advice.